Eicke Latz Highly Cited Researcher Our Scientific Director, Prof. Dr. Eicke Latz, is one of the world's most influential researchers of 2025, as the recently published list of “Highly Cited Researchers” by Clarivate shows. www.drfz.de/neuigkeiten/...
Eicke Latz unter den weltweit meistzitierten Forschenden - DRFZ
Eicke Latz vom Deutschen Rheuma-Forschungszentrum Berlin, ein Leibniz-Institut ist Highly Cited Researcher 2025
drfz.de
Epigenetic Imprints of Immune Memory across the Human Body: Andreas Radbruch from DRFZ and colleagues discovered how immune cells are epigenetically imprinted to provide protection against repeated infections by pathogens - published in the journal Immunity & Inflammation. bit.ly/3IQnUNW
Wie Epigenetik das Immungedächtnis im gesamten menschlichen Körper prägt - DRFZ
Jun Dong aus der Gruppe von Andreas Radbruch vom DRFZ zeigt wie Epigenetik das Immungedächtnis im gesamten menschlichen Körper prägt
bit.ly
#Rheuma wird bei #Frauen oft später diagnostiziert als bei Männern – aber keineswegs, weil sie seltener betroffen sind. Auf dem Deutschen #Rheumatologiekongress diskutiert eine Expertin vom @drfzberlin.bsky.social geschlechtsspezifische Unterschiede.
Dr. Lisa Budzinski from DRFZ was awarded the Klaus Goerttler Prize at the 35th Conference of the DGfZ. This prize recognizes the exceptional research work of the biotechnologist, who completed her PhD this year at the German Rheumatology Research Center Berlin, a Leibniz Institute. bit.ly/42jhn4M
Lisa Budzinski honored with Klaus Goerttler Prize Prize - DRFZ
Award by the German Society of Cytometry Dr. Lisa Budzinski was awarded the Klaus Goerttler Prize at the 35th Conference of the German Society for…
bit.ly
On September 9, 2025, PD Dr. rer. nat. Mir-Farzin Mashreghi gave his inaugural lecture “From Immune Response to Long-Term Immunity". On June 16, 2025, Mir-Farzin Mashreghi habilitated at Charité – Universitätsmedizin Berlin, thereby qualifying him to teach experimental pediatrics. bit.ly/4p7JrBY
NLRP3 as a driver of inflammation Eicke Latz from DRFZ and colleagues have published a review about NLRP3 in the journal Nature Immunology. The article summarizes the current state of knowledge about this key molecule driving atherosclerosis, Alzheimer's disease, and gout. bit.ly/3JyPFdO
Our colleagues from the DRFZ, together with the @mpiib-berlin.mpg.de, delighted 1686 guests with the fascinating world of research until late into the Long Night of Science on June 28, 2025. Thanx to all making the #lndw2025 an unforgettable event! www.drfz.de/en/neuigkeit...
Eicke Latz is a new BBAW member Prof. Dr. Eicke Latz, Scientific Director of the German Rheumatology Research Center, a Leibniz-Institute, has been welcomed as a full member of the Berlin-Brandenburg Academy of Sciences and Humanities (BBAW). More: www.drfz.de/en/neuigkeit...
Im Rahmen der Gremiensitzungen im Vorfeld des Leibniztages wurden drei neue Mitglieder in die Akademie aufgenommen: der Neurobiologe Frank Bradke (@dzne.science), der Mediziner Eike Latz (@drfzberlin.bsky.social) und der Lebensmitteltechnologe Alexander Mathys (@ethz.ch). Herzlich willkommen!
Six relay teams from the DRFZ took part in the 5x5 km Team Relay of Berliner Wasserbetriebe on June 5, 2025. More plus gallery: www.drfz.de/en/neuigkeit...
Andreas Radbruch and colleagues from the #DRFZ find a mechanism how surface CD69 negative memory T cells are retained in the bone marrow. Read more: www.drfz.de/en/neuigkeit...
Our new movie about the DRFZ is now on YouTube A lot is new at the DRFZ. After the change of institute management, the DRFZ image was refreshed and now the new short film about the DRFZ's research tasks is ready. youtu.be/uBchCSyo-Do
Film about DRFZ
YouTube video by Deutsches Rheuma-Forschungszentrum Berlin
youtu.be
Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research The DRFZ is part of the new Cluster of Excellence Read more at our website: www.drfz.de/en/neuigkeit...
Early recognition, targeted intervention, staying healthy: ImmunoPreCept unites top Berlin research - DRFZ
The German Rheumatology Research Center Berlin, a Leibniz Institute, is a partner in the new Berlin Cluster of Excellence ImmunoPreCept.
drfz.de
We like to invite you to join the 35th Annual Meeting of the German Society for Cytometry this year in Dresden on September 9-12. Early bird registration & abstract submission until 31st of May! For more information please have a look at the meeting website: dgfz.org/2025/
Book a Scientist – am 3. Juni 2025 Das „Speed-Dating mit der Wissenschaft“ bietet Wissenschaftsinteressierten die Gelegenheit, in individuellen Online-Gesprächen die Forschung von Wissenschaftler:innen der Leibniz-Gemeinschaft kennenzulernen - mit dabei Johannes Groffmann vom DRFZ. bit.ly/3EYiizd
Der Kartenverkauf hat begonnen! Die Karten kosten in diesem Jahr nur 5 EUR! Feiern Sie mit uns das 25 jährige Jubiläum der Langen Nacht der Wissenschaften am 28. Juni 2025 ab 17:00 Uhr bis Mitternacht. Das Programm am DRFZ: www.drfz.de/veranstaltun...
Lange Nacht der Wissenschaften 2025 - DRFZ
Jährlich im Juni laden das DRFZ und über 50 weitere Berliner Institutionen zur Langen Nacht der Wissenschaften ein.
drfz.de
Andreas Radbruch, #DRFZ & #EFIS, welcomes the participants of the EFIS symposium "The Reaction to #SARS-CoV-2: an Immunological Retrospective" taking place in Berlin today. www.efis.org/news/efis-sy...
Alexandra Damerau and Timo Gaber, DRFZ and Charité, have used an in-vitro 3D model to show that mechanical stress can attenuate inflammation-induced cartilage degradation in osteoarthritis. They also demonstrated the anti-inflammatory effect of JAK inhibitors. More: bit.ly/3DUuujU
3D model for cartilage degradation - DRFZ
Alexandra Damerau and Dr. Timo Gaber, DRFZ and Charité, used an in-vitro 3D model to investigate mechanical influences on cartilage tissue.
bit.ly
The local application of deferoxamine (DFO) significantly accelerates fracture healing, as a systematic review and meta-analysis of 21 studies compiled by Dr. Paula Hoff and Dr. Timo Gaber from DRFZ and Charité - Universitätsmedizin Berlin shows. More at our website: bit.ly/4l0eGwG
Period blood for research? Ping Shen in an ARTE interview “Are we wasting period blood?” Dr. Ping Shen from Pitzer Laboratory for Osteoarthritis Research at DRFZ even collects menstrual blood for her research. Link to video with interview: bit.ly/4hJN8c8 Link to News at DRFZ website: bit.ly/4hSqCOv
Join EFIS on 4 April for an encounter dedicated to exploring - from an immunological standpoint - the unresolved issues and misconceptions of COVID-19 vaccination five years after the WHO declaration of the pandemic. Program: www.efis.org/.../Reaction.... Register: www.efis.org/events/efis-...
How does SARS-CoV-2 lead to the multisystem inflammatory syndrome in children, a rare, potentially fatal condition? www.nature.com/articles/s41... High levels of TGFβ interfere with the child's response to control Epstein Barr virus, leading to its reactivation and severe inflammation @nature.com
TGFβ links EBV to multisystem inflammatory syndrome in children - Nature
Multisystem inflammatory syndrome following SARS-CoV-2 infection results from increased serum levels of TGFβ, which impairs the reactivation of virus-specific T cells.
nature.com
Exiting publication in Nature by DRFZ researchers: Congratulations! Original publication: bit.ly/3Fn63Mt News DRFZ: bit.ly/4kJ1AUq
@mashreghilab.bsky.social · 2y agoOur latest study in @nature.com reveals how #TGFβ drives Epstein-Barr Virus (#EBV) reactivation in multisystem inflammatory syndrome in #children (#MISC, #PIMS) following #COVID19. @drfzberlin.bsky.social @mashreghilab.bsky.social 🔗 Read here:https://www.nature.com/articles/s41586-025-08697-6
Prof. Dr. Thomas Krieg is the new President of the Board of Trustees of the DRFZ, succeeding Prof. Dr. Elisabeth Märker-Hermann. Dr. med. Julia Rautenstrauch is elected Vice President of the Board of Trustees. www.drfz.de/en/neuigkeit...
The DRFZ has restructured its research areas and now comprises four areas. Two new program areas have been formed from the previously largest program area Pathophysiology of Rheumatic Inflammation: Learn more: www.drfz.de/en/research-...
The DRFZ has restructured its research areas and now comprises four areas. Two new programme areas have been formed from the previously largest program area Pathophysiology of Rheumatic Inflammation: Learn more: www.drfz.de/en/research-...
DRFZ with a new look: modern logo and new website The German Rheumatology Research Centre, a Leibniz Institute, (DRFZ) now has a fresh new look! With a new logo and a revised colour scheme, the DRFZ reflects its future-oriented approach to rheumatological research: www.drfz.drfz.de
Robert-Koch-Postdoktorandenpreis für den Themenbereich Immunologie (€ 5.000) / Bewerbungsschluss: 14. März 2025 Die DGfI hat ein Vorschlagsrecht für den Robert-Koch-Postdoktorandenpreis im Bereich Immunologie. Mehr Informationen unter: dgfi.org/preise/koch-...
Chiara Romagnani Liaison Group Leader at DRFZ is a new member of the Leopoldina. This membership is considered one of the highest scientific honors and recognitions in Germany and beyond. Congratulations! bit.ly/42XMdkQ
Congratulations to Yola Gerking, University of Bergen, Norway, for the best poster presentation and Matthieu van Tilbeurgh, CEA, France, for the best short talk of the German Mass Cytometry User Forum.
